223 related articles for article (PubMed ID: 17502047)
1. Therapy of pulmonary arterial hypertension in systemic sclerosis: an update.
Denton CP; Nihtyanova SI
Curr Rheumatol Rep; 2007 May; 9(2):158-64. PubMed ID: 17502047
[TBL] [Abstract][Full Text] [Related]
2. Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).
Sobanski V; Launay D; Hachulla E; Humbert M
Curr Rheumatol Rep; 2016 Feb; 18(2):10. PubMed ID: 26841964
[TBL] [Abstract][Full Text] [Related]
3. An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature.
Sundaram SM; Chung L
Curr Rheumatol Rep; 2018 Feb; 20(2):10. PubMed ID: 29488016
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review.
Bazan IS; Mensah KA; Rudkovskaia AA; Adonteng-Boateng PK; Herzog EL; Buckley L; Fares WH
Respir Med; 2018 Jan; 134():42-46. PubMed ID: 29413506
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary arterial hypertension and systemic sclerosis].
Launay D; Humbert M; Hachulla E
Presse Med; 2006 Dec; 35(12 Pt 2):1929-37. PubMed ID: 17159719
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue disease-related pulmonary arterial hypertension.
Thakkar V; Lau EM
Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):22-38. PubMed ID: 27421214
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
Kolstad KD; Li S; Steen V; Chung L;
Chest; 2018 Oct; 154(4):862-871. PubMed ID: 29777655
[TBL] [Abstract][Full Text] [Related]
8. Update in systemic sclerosis-associated pulmonary arterial hypertension.
Gashouta MA; Humbert M; Hassoun PM
Presse Med; 2014 Oct; 43(10 Pt 2):e293-304. PubMed ID: 25179278
[TBL] [Abstract][Full Text] [Related]
9. Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol.
Calderone A; Stevens W; Prior D; Nandurkar H; Gabbay E; Proudman SM; Williams T; Celermajer D; Sahhar J; Wong PK; Thakkar V; Dwyer N; Wrobel J; Chin W; Liew D; Staples M; Buchbinder R; Nikpour M
BMJ Open; 2016 Dec; 6(12):e011028. PubMed ID: 27932335
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary arterial hypertension in connective tissue disease].
Cottin V
Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
[TBL] [Abstract][Full Text] [Related]
12. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
Coghlan JG; Galiè N; Barberà JA; Frost AE; Ghofrani HA; Hoeper MM; Kuwana M; McLaughlin VV; Peacock AJ; Simonneau G; Vachiéry JL; Blair C; Gillies H; Miller KL; Harris JHN; Langley J; Rubin LJ;
Ann Rheum Dis; 2017 Jul; 76(7):1219-1227. PubMed ID: 28039187
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
Lewis C; Sanderson R; Vasilottos N; Zheutlin A; Visovatti S
Heart Fail Clin; 2023 Jan; 19(1):45-54. PubMed ID: 36435572
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary arterial hypertension complicating connective tissue diseases.
Hassoun PM
Semin Respir Crit Care Med; 2009 Aug; 30(4):429-39. PubMed ID: 19634082
[TBL] [Abstract][Full Text] [Related]
15. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.
Thakkar V; Nikpour M; Stevens WM; Proudman SM
Intern Med J; 2015 Mar; 45(3):248-54. PubMed ID: 25735576
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension in connective tissue diseases.
Goldberg A
Cardiol Rev; 2010; 18(2):85-8. PubMed ID: 20160534
[TBL] [Abstract][Full Text] [Related]
17. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets.
Dimitroulas T; Giannakoulas G; Karvounis H; Settas L; Kitas GD
Curr Pharm Des; 2012; 18(11):1457-64. PubMed ID: 22364130
[TBL] [Abstract][Full Text] [Related]
19. Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group.
Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
J Rheumatol; 2010 Jan; 37(1):105-15. PubMed ID: 19955042
[TBL] [Abstract][Full Text] [Related]
20. New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension.
Mullin CJ; Mathai SC
Curr Opin Rheumatol; 2017 Nov; 29(6):561-567. PubMed ID: 28817465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
